Exagen Inc.
A medical diagnostics company, Exagen makes blood tests that help rheumatologists tell apart autoimmune conditions like lupus and rheumatoid arthritis. Its flagship product, AVISE CTD, is processed in a single lab in Vista, California, with results typically ready in about five business days. Founded in 2002, the company grows its line of AVISE-branded tests, and the "CTD" in its flagship test's name stands for connective tissue disease—the family of illnesses it helps doctors sort out.
Sold 129.2K
Sold 801.4K
Bought 167
Bought 425.0K
Sold 225.2K
Granted 818.3K · Bought 130.4K · Sold 92.7K
Granted 316.5K · Bought 22.3K · Sold 22.1K
Granted 276.0K · Sold 29.0K
Granted 165.4K · Sold 9.5K
Granted 24.7K
Granted 125.0K
Granted 87.5K
Bought 1.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Tullis James L LDirector · 39 transactions | — | 3.12Mas of Aug 2021 | — | — | 129.2K |
| NMSIC Focused LLC +2 co-filers10% owner · 4 transactions | — | 2.57Mas of Sep 2019 | — | — | — |
| Sun Mountain Capital Partners LLC +1 co-filer10% owner · 4 transactions | — | 1.76Mas of Mar 2025 | — | — | 801.4K |
| Tullis Dickerson Capital Focus III, L.P. +3 co-filers10% owner · 4 transactions | — | 1.63Mas of Mar 2020 | — | — | — |
| Tullis James L L +1 co-filer10% owner · 1 transaction | — | 1.54Mas of Jun 2023 | — | 167 | — |
| Mnaymneh Sami +3 co-filers10% owner · 2 transactions | — | 1.27Mas of Sep 2019 | — | 425.0K | — |
| Hunt Guaranty Inc. +3 co-filers10% owner · 17 transactions | — | 1.26Mas of Jan 2021 | — | — | 225.2K |
| Aballi JohnPresident and CEO, Director · 14 transactions | — | 880.2K | 818.3K | 130.4K | 92.7K |
| Black Jeffrey G.Chief Financial Officer · 7 transactions | — | 342.4K | 316.5K | 22.3K | 22.1K |
| Adawi KamalCFO and Corporate Secretary · 10 transactions | — | 247.2Kas of Mar 2024 | 276.0K | — | 29.0K |
| Hazeltine MarkChief Business Officer · 6 transactions | — | 190.2Kas of Mar 2023 | 165.4K | — | 9.5K |
| Pallares EbetuelDirector · 9 transactions | — | 145.4Kas of Apr 2020 | 24.7K | — | — |
| Rocca Fortunato R.President and CEO, Director · 3 transactions | — | 120.7Kas of Mar 2022 | 125.0K | — | — |
| Zack DebraChief Medical Officer · 3 transactions | — | 84.3Kas of Mar 2022 | 87.5K | — | — |
| Johnson Wendy S.Director · 1 transaction | — | 1.0Kas of Sep 2021 | — | 1.0K | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -730.2K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.